Alexion Provides Update on Previously Communicated November 2013 Voluntary Nationwide Recall of Two Lots of Soliris (eculizumab) Concentrated Solutio

16-12-2013 Business Wire HealthComments (0)

Alexion PharmaceuticalsPharmaceutical

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. today is providing further information regarding a previously communicated voluntary recall of two lots of eculizumab Concentrated Solution for Intravenous Infusion.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top